(Eye[TA])
12,997 results
  • Post-treatment residual masses in orbital lymphoma: incidence, risk factors, and prognostic impact. [Journal Article]
    Eye (Lond). 2026 Oct 08. [Online ahead of print]Choi YA, Yang MK, Sa HSE
  • CONCLUSIONS: Post-treatment RMs were common in OL, particularly among individuals with advanced-stage, large, or posteriorly located tumours. Among those with RMs, AJCC N1 stage and high-grade histology were independent predictors of relapse. Given the risk of relapse despite standard first-line therapy, intensified treatment and closer surveillance should be considered in this high-risk subgroup.